Pliant Therapeutics (PLRX)

• Market cap: $76.8M
• 1 day: 0%
• 5 days: -2.34%
• 1 month: 1.63%
• 3 months: -28.16%
• 6 months: -14.38%
• Year to date: 0%
• 1 year: -88.36%
• 5 years: -94.92%
• 10 years: -94.13%
• Sector: Healthcare
• Industry: Biotechnology

About: Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Employees: 171